Cell Signaling Technology

Antibodies Built for Cell Therapy Breakthroughs

CST Innovations at SITC 2026

Heading to SITC in Phoenix in November? Stop by the CST booth #811 to learn about our new solutions for cell therapy development. We’re excited to share our new solutions for single cell analysis, and multiplex IHC and more:

  • New GMP-grade antibody conjugates to detect and enrich G4S linker-containing CAR cells in clinical manufacturing and QC
  • New, flexible preclinical options for specific CAR+ cell detection in our expanding suite of CAR-engineered cell characterization tools
  • New InTraSeq® F' Antibody Cocktail enables correlating gene expression with the actual drivers of cell fate in a single workflow, bridging the gap between the transcriptome and the functional intracellular proteome
  • New additional host species of your trusted CST FFPE IHC antibody clones (feline, mouse, chicken, and rabbit) to enable multiplexing, as well as species-specific secondary antibodies to complete your IHC workflow

Attend our SITC 2026 Tech Talk 

Saturday, November 7, 2026 | 7:35 PM–7:50 PM | Exhibit Hall Theater

Universal CAR-T Detection: From Discovery Reagents to Clinical Manufacturing, presented by Samuel Jensen, PhD (Cell Signaling Technology)

 

Learn about: 

  • Universal CAR Detection with recombinant antibodies targeting G4S CAR linkers to enable target-agnostic isolation and detection across diverse constructs, eliminating the need for custom reagents.

  • Bench-to-Clinic Scalability with versatile tools to support consistent workflows from preclinical research through clinical manufacturing and quality control.

  • High-Resolution Profiling to complement bulk flow cytometry by resolving CAR expression and cell phenotype at the single-cell level, using InTraSeq single-cell analysis technology

Don't Miss SITC 2026 Research Posters Presented by CST

Leveraging Anti-Linker Monoclonal Antibodies to Interrogate Chimeric Antigen Receptor Functionality

Presented by Amrik Singh, PhD, Cell Signaling Technology

Poster #234

Learn about using anti-linker antibody conjugates to enrich CAR+ cells


Saturday, November 7 | 12:15–1:45 PM, 6:40–8:10 PM | Exhibit Hall

Positive Selection of CAR-T Cells Using a GMP-Compliant Anti-G4S Linker Mononoclonal Antibody

 

Presented by Samuel Jensen, PhD, Cell Signaling Technology

 

Poster #194

 

Understand how antibody conjugates for CAR+ enrichment and detection in manufacturing and QC can simplify workflows


Saturday, November 7 | 12:15–1:45 PM, 6:40–8:10 PM | Exhibit Hall